Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

FARMAKEIO OUTSOURCING LLC

US Class II Ongoing · initiated 2025-10-14

CGMP Deviations: Potential presence of metal particulate matter

FARMAKEIO OUTSOURCING LLC

US Class II Ongoing · initiated 2025-10-14

CGMP Deviations: Potential presence of metal particulate matter

FARMAKEIO OUTSOURCING LLC

US Class II Ongoing · initiated 2025-10-14

CGMP Deviations: Potential presence of metal particulate matter

FARMAKEIO OUTSOURCING LLC

US Class II Ongoing · initiated 2025-10-14

CGMP Deviations: Potential presence of metal particulate matter

FARMAKEIO OUTSOURCING LLC

US Class II Ongoing · initiated 2025-10-14

CGMP Deviations: Potential presence of metal particulate matter

FARMAKEIO OUTSOURCING LLC

US Class II Ongoing · initiated 2025-10-14

CGMP Deviations: Potential presence of metal particulate matter

FARMAKEIO OUTSOURCING LLC

US Class II Ongoing · initiated 2025-10-14

CGMP Deviations: Potential presence of metal particulate matter

FARMAKEIO OUTSOURCING LLC

US Class II Ongoing · initiated 2025-10-14

CGMP Deviations: Potential presence of metal particulate matter

FARMAKEIO OUTSOURCING LLC

US Class II Ongoing · initiated 2025-10-14

CGMP Deviations: Potential presence of metal particulate matter

FARMAKEIO OUTSOURCING LLC

US Class II Ongoing · initiated 2025-10-14

CGMP Deviations: Potential presence of metal particulate matter

FARMAKEIO OUTSOURCING LLC

US Class II Ongoing · initiated 2025-10-14

CGMP Deviations: Potential presence of metal particulate matter

Teva Pharmaceuticals USA, Inc

US Class II Ongoing · initiated 2025-10-13

Subpotent drug; Clavulanate Potassium component

Lannett Company Inc.

US Class II Ongoing · initiated 2025-10-10

Failed Dissolution Specifications

The Harvard Drug Group LLC

US Class II Ongoing · initiated 2025-10-10

Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .

The Harvard Drug Group LLC

US Class II Ongoing · initiated 2025-10-10

Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .

Endo USA, Inc.

US Class III Ongoing · initiated 2025-10-10

Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.

Samsung Bioepis Co., Ltd.

US Class II Ongoing · initiated 2025-10-10

Lack of Assurance of Sterility.

Endo USA, Inc.

US Class III Ongoing · initiated 2025-10-10

Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.

QuVa Pharma, Inc.

US Class II Ongoing · initiated 2025-10-10

Presence of Particulate Matter

Endo USA, Inc.

US Class III Ongoing · initiated 2025-10-10

Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.

Endo USA, Inc.

US Class III Ongoing · initiated 2025-10-10

Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.

Alembic Pharmaceuticals Limited

US Class III Ongoing · initiated 2025-10-10

Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

CA BOTANA International, Inc.

US Class II Ongoing · initiated 2025-10-10

CGMP Deviations

CA BOTANA International, Inc.

US Class II Ongoing · initiated 2025-10-10

CGMP Deviations

CA BOTANA International, Inc.

US Class II Ongoing · initiated 2025-10-10

CGMP Deviations